Orthosiphon aristatus, The Kidney Healer: Medicinal Uses, Recipes and Formulations

Orthosiphon aristatus, commonly known as Cat's Whiskers, Java Tea, or Kumis Kucing, is a perennial herb of the Lamiaceae family whose medicinal value is profoundly centered on the flushing and cleansing of the urinary tract. It is one of the most clinically validated botanical agents for promoting renal elimination and managing urinary calculi, a property attributed to its unique combination of caffeic acid derivatives, particularly rosmarinic acid, and highly oxygenated diterpenoids that collectively enhance diuresis, inhibit crystal adhesion, and reduce inflammation within the renal parenchyma. Beyond its renowned nephroprotective and diuretic effects, Orthosiphon aristatus is a comprehensive metabolic regulator, exhibiting potent anti-inflammatory, antihypertensive, hypoglycemic, and antimicrobial actions. The leaves, in particular, are exceptionally rich in rosmarinic acid, which constitutes the majority of the phenolic content in aqueous preparations, and methylripariochromene A, a benzochromene that has demonstrated continuous blood pressure reduction in hypertensive models. This dual mechanism of action, addressing both the mechanical flushing of the urinary tract and the underlying metabolic and inflammatory contributors to stone formation, makes it a uniquely balanced agent for urological and metabolic conditions. Clinical studies have demonstrated that Orthosiphon aristatus is comparable to alpha-blockers in facilitating stone expulsion following extracorporeal shockwave lithotripsy, with treatment success rates favoring the herbal preparation. This comprehensive action on the urinary, cardiovascular, and metabolic systems makes it a valuable phytomedicine for conditions characterized by fluid retention, urinary calculi, and metabolic imbalance.

Medicinal Uses: Summary of Primary and Secondary Actions

Primary Actions

1. Diuretic and Nephroprotective

Orthosiphon aristatus is a premier botanical agent for promoting urinary flushing and protecting renal tissue. The primary mechanism is the enhancement of renal blood flow and glomerular filtration, mediated by flavonoids and saponins that increase urine volume without depleting electrolytes. The European Scientific Cooperative on Phytotherapy (ESCOP) endorses Orthosiphon leaf preparations for flushing the urinary tract in inflammatory conditions and renal gravel, as well as supporting the treatment of bacterial urinary tract infections. Beyond mechanical flushing, the plant demonstrates direct nephroprotective activity. The total flavonoids from Orthosiphon aristatus significantly decreased serum creatinine, blood urea nitrogen, serum calcium, and serum phosphorus in calcium oxalate-induced kidney stone models, indicating protection against renal injury. The mechanism involves attenuation of oxidative stress and apoptosis in renal tubular epithelial cells through activation of the EGFR/PI3K/AKT pathway. This dual action of flushing and tissue protection makes it uniquely valuable for both prevention and management of urolithiasis.

2. Anti-urolithic and Stone Expulsion

Orthosiphon aristatus is specifically indicated for the management of urinary tract calculi. A clinical study of 84 patients undergoing extracorporeal shockwave lithotripsy randomized patients to receive either Orthosiphon aristatus or the alpha-blocker doxazosin for three months. The stone-free rate was 47.6 percent in the Orthosiphon group and 45.2 percent in the alpha-blocker group, while treatment success rates were 69.0 percent and 54.8 percent respectively. The differences were not statistically significant, establishing non-inferiority of the herbal preparation to standard medical expulsive therapy. The mechanism involves inhibition of calcium oxalate crystal adhesion to renal tubular cells and reduction of crystal deposition within the kidney. The flavonoids inhibit oxidative stress-induced crystal adhesion, while the increased urine flow mechanically facilitates stone passage. This makes Orthosiphon a safe and effective alternative for medical expulsive therapy following lithotripsy.

3. Antihypertensive and Cardiovascular Protective

Orthosiphon aristatus demonstrates significant antihypertensive activity, validated through both traditional use and preclinical investigation. In Javanese traditional medicine, the water decoction of leaves has been prescribed specifically for hypertension. The chloroform-soluble fraction of the decoction inhibits contractile responses in rat thoracic aorta smooth muscle stimulated with potassium chloride, indicating a direct vasorelaxant effect. Methylripariochromene A, a major constituent in the water decoction, exhibited a continuous decrease in systolic blood pressure after subcutaneous administration in conscious stroke-prone spontaneously hypertensive rats. A study of rural Thai people identified Orthosiphon aristatus as the species with the highest number of use reports and use value for cardiovascular diseases. The antihypertensive mechanism involves direct smooth muscle relaxation and possibly inhibition of the Na+,K+-ATPase enzyme, as hexane extracts showed potent inhibitory activity with an IC50 of 8.5 micrograms per milliliter.

4. Anti-inflammatory and Antioxidant

Orthosiphon aristatus exhibits potent anti-inflammatory activity mediated primarily through rosmarinic acid. The plant has demonstrated efficacy in chronic liver injury, arthritis, cardiovascular diseases, and neurodegenerative disorders through its anti-inflammatory mechanisms. The extract inhibits the expression of TNF-alpha, IL-6, IL-1beta, COX-2, and iNOS, key mediators of the inflammatory cascade. In a model of Alzheimer-like pathology, the methanolic extract at 300 milligrams per kilogram significantly reduced these inflammatory factors while increasing BDNF levels, suggesting neuroprotective potential. The antioxidant activity is attributed to the high phenolic content, particularly rosmarinic acid and caffeic acid derivatives, which scavenge free radicals and enhance endogenous antioxidant defenses.

5. Antidiabetic and Metabolic Regulatory

Orthosiphon aristatus demonstrates significant antidiabetic potential through the inhibition of protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of insulin signaling. Seven pimarane diterpenoids and rosmarinic acid from the plant exhibited PTP1B inhibitory activity. Methyl rosmarinate was identified as a PTP1B inhibitor that improves insulin sensitivity in diabetic mice. The traditional use of Orthosiphon aristatus in southern China for treating diabetes and kidney diseases provides ethnomedicinal validation for this activity. The plant has also demonstrated hypolipidemic and anti-obesity potential, addressing the broader metabolic syndrome that often accompanies diabetes.

Secondary Actions

1. Antimicrobial and Antifungal

Orthosiphon aristatus demonstrates antimicrobial activity against both Gram-positive and Gram-negative bacteria. Compounds isolated from the aerial parts, including oraristatin A and oraristatinoside A, weakly inhibited both Gram-positive and Gram-negative bacteria with minimum inhibitory concentrations of 150 to 300 micromolar. Other isolated phenolic metabolites suppressed the growth of three Gram-positive bacteria and Candida albicans with MIC values of 75 to 150 micromolar. The antimicrobial action is linked to the phenolic acids, flavonoids, and diterpenoids. This activity supports the traditional use of the plant for urinary tract infections, where the flushing action of the diuretic combines with direct antimicrobial effects to address bacterial colonization.

2. Hepatoprotective

The anti-inflammatory and antioxidant properties of Orthosiphon aristatus extend to protection of hepatic tissue. The plant has demonstrated hepatoprotective potential in the comprehensive pharmacological profile documented in scientific literature. The mechanism involves inhibition of pro-inflammatory cytokines, reduction of oxidative stress, and preservation of hepatocellular integrity. While specific clinical trials on hepatoprotection are lacking, the strong anti-inflammatory and antioxidant foundation provides a rational basis for this secondary action.

3. Anticancer Potential

Preclinical studies have identified cytotoxic activity in diterpenoids isolated from Orthosiphon aristatus. Compounds from the aerial parts demonstrated weak inhibitory activity on the proliferation of SKOV3, DU145, and PC-3 cancer cell lines. While this activity is preliminary and requires extensive further investigation, it suggests a potential avenue for future research into the plant's anticancer properties.

Critical Safety Warning: Toxicity and Dosage

Orthosiphon aristatus is generally regarded as safe when used at traditional therapeutic doses. The European Medicines Agency assessment report states that Orthosiphonis folium is safe for patients and can be used without supervision of a medical practitioner for the traditional indication of increasing urine to achieve flushing of the urinary tract. A clinical study in nephrolithiasis patients receiving an aqueous dry extract at a daily dose corresponding to 3.2 to 3.6 grams of dried leaves reported adverse effects of 27.8 percent in the first week and 2.8 percent in the second week in the java tea group, compared to 17.5 percent in both weeks in the placebo group. The adverse effects included myofascial symptoms, fatigue, back pain, abdominal pain, arthritis, gastrointestinal disturbance, and headache. These were not considered correlated with java tea consumption, and the reported adverse effects significantly reduced in the second week within the java tea group.

However, several critical safety considerations must be noted. The use of Orthosiphon aristatus is contraindicated in patients with edema due to cardiac or renal insufficiency, as the increased fluid load may exacerbate these conditions. During treatment, fluid intake must be increased to at least two liters per day to prevent dehydration from the diuretic effect. There is one case report of hepatitis in a 25-year-old female patient who had taken two herbal products, one containing green tea and one containing Orthosiphon stamineus, for two months before experiencing asthenia, icterus, and pruritus. The outcome was favorable after discontinuation of both products, and the authors noted that green tea-containing products have been associated with liver disorders.

The use of Orthosiphon aristatus is not recommended in children and adolescents under 18 years of age due to insufficient data. Its use during pregnancy and lactation is also not recommended due to insufficient safety data. The plant interacts with lithium, and concomitant use should be avoided. Patients with symptoms such as fever, dysuria, spasms, or blood in the urine should seek medical advice before using the plant. No cases of overdose have been reported, and preclinical genotoxicity studies with extracts prepared from the powder contained in marketed products revealed no mutagenic effects in the Ames test. However, carcinogenicity and reproductive toxicity studies have not been performed.

Medicinal Parts

The leaves are the primary medicinal part, with the aerial parts also utilized.

Leaves: The premier medicinal part, officially recognized in pharmacopoeias as Orthosiphonis folium. The leaves contain the highest concentration of rosmarinic acid, caffeic acid derivatives, diterpenoids, and flavonoids. The leaves are the source material for all diuretic, anti-urolithic, antihypertensive, and metabolic preparations. They are typically dried and used as a tea or standardized extract. The hot water extract is particularly rich in caffeic acid derivatives, which constitute 94.5 percent of the total identified phenolics in aqueous preparations, with rosmarinic acid being the major compound.

Aerial Parts: The aerial parts, including stems and leaves, are used in traditional preparations and have been the subject of extensive phytochemical investigation. More than 80 diterpenoids have been isolated from the aerial parts, including isopimarane, staminane, secoisopimarane, and norstaminane skeletons, many of which are unique to this species. The aerial parts are used in traditional medicine for the same indications as the leaves.

Phytochemistry

The pharmacological activity of Orthosiphon aristatus is driven by a unique synergy of phenolic acids, diterpenoids, flavonoids, and volatile oils.

1. Phenolic Acids and Caffeic Acid Derivatives (Leaves)

This is the signature chemical class responsible for the diuretic, anti-inflammatory, and antioxidant effects. Rosmarinic acid is the predominant phenolic compound, along with 2,3-dicaffeoyltartaric acid. In an aqueous methanolic extract, caffeic acid derivatives constituted 67 percent of total identified phenolics, while in a hot water extract comparable to herbal tea, this proportion increased to 94.5 percent. Rosmarinic acid has been extensively studied for its anti-inflammatory efficacy in chronic liver injury, arthritis, cardiovascular diseases, and neurodegenerative disorders. The bioactivity is mediated through inhibition of pro-inflammatory cytokines, including TNF-alpha, IL-6, IL-1beta, COX-2, and iNOS.

2. Diterpenoids (Aerial Parts)

More than 80 diterpenoids have been isolated from Orthosiphon aristatus, representing a remarkable chemodiversity. The major classes include isopimarane, staminane, secoisopimarane, secostaminane, and norstaminane skeletons. Orthosiphols A and B, and orthosiphonones A and B are representative isopimarane diterpenoids. Neoorthosiphols A and B, and staminols A and B represent the staminane type. These diterpenoids are characterized by a high degree of oxygenation and multiple acyl substitution, structural features that contribute to their pharmacological activities. Seven pimarane diterpenoids from Orthosiphon aristatus exhibited PTP1B inhibitory activity, a mechanism for improving insulin sensitivity.

3. Flavonoids and Methylripariochromene A (Leaves)

The leaves contain lipophilic flavones and flavonol glycosides, including sinensetin, eupatorin, and 3'-hydroxy-5,6,7,4'-tetramethoxyflavone. Methylripariochromene A, a benzochromene, is a major constituent in the water decoction and has demonstrated continuous reduction in systolic blood pressure in hypertensive rats. The total flavonoids from Orthosiphon aristatus are the primary active constituents responsible for the anti-urolithic effects, inhibiting calcium oxalate crystal adhesion and reducing renal injury through activation of the EGFR/PI3K/AKT pathway.

4. Volatile Oils and Terpenoids (Leaves)

The essential oil of Orthosiphon aristatus leaves is primarily composed of terpene hydrocarbons. beta-Caryophyllene is the predominant sesquiterpenoid, accounting for significant proportions of the essential oil. Other major compounds include patinitic acid, beta-selinene, alpha-guaiene, delta-cadinene, beta-caryophyllene oxide, calarene, beta-elemene, and alpha-humulene, each accounting for more than 3 percent of the essential oil. These volatile compounds contribute to the antimicrobial and aromatic properties of the plant.

Mechanisms of Action

1. Diuretic Action: Enhanced Renal Perfusion and Filtration

The diuretic mechanism of Orthosiphon aristatus is mediated through multiple complementary pathways. The flavonoids and saponins increase renal blood flow, enhancing glomerular filtration rate and urine production. The increased urine volume mechanically flushes the urinary tract, reducing the concentration of solutes that can precipitate into stones and facilitating the passage of existing calculi. The plant also alkalinizes the urine, as demonstrated in a study where Java tea led to statistically significant increases in urinary pH. This alkalinization is particularly relevant for uric acid stones, which dissolve more readily in alkaline urine. The combination of increased flow and altered pH creates a less favorable environment for crystal formation and aggregation.

2. Anti-urolithic Action: Inhibition of Crystal Adhesion and Deposition

The anti-urolithic mechanism operates at the cellular level within the renal tubules. The total flavonoids from Orthosiphon aristatus protect human renal tubular epithelial cells from oxidative stress induced by supersaturated oxalate, inhibit calcium oxalate crystal adhesion to these cells, and reduce apoptosis. The molecular mechanism involves activation of the EGFR/PI3K/AKT pathway, which promotes cell survival and reduces oxidative damage. In animal models of calcium oxalate crystal deposition, the total flavonoids significantly decreased serum creatinine, blood urea nitrogen, serum calcium, and serum phosphorus levels, indicating protection against renal injury and reduced crystal deposition. This cellular protection prevents the initial steps of stone formation, namely crystal retention within the kidney.

3. Antihypertensive Action: Vasorelaxation and Ion Channel Modulation

The antihypertensive mechanism involves direct relaxation of vascular smooth muscle. The chloroform-soluble fraction of the water decoction inhibits contractile responses in rat thoracic aorta smooth muscle stimulated with potassium chloride, indicating blockade of calcium channels or interference with calcium-mediated contraction. Methylripariochromene A, a major constituent, produces a continuous decrease in systolic blood pressure in conscious hypertensive rats after subcutaneous administration. Additionally, hexane extracts of Orthosiphon aristatus demonstrate potent inhibitory activity on Na+,K+-ATPase from rat brain, with an IC50 of 8.5 micrograms per milliliter. This enzyme regulates cellular sodium and potassium balance in vascular smooth muscle; its inhibition can lead to vasodilation and reduced peripheral resistance.

4. Anti-inflammatory Action: Cytokine Inhibition and NF-kappaB Modulation

The anti-inflammatory action of Orthosiphon aristatus is mediated through rosmarinic acid and related phenolic compounds. The extract inhibits the expression of TNF-alpha, IL-6, IL-1beta, COX-2, and iNOS, key mediators of the inflammatory cascade. This broad-spectrum cytokine inhibition is complemented by inhibition of the NF-kappaB pathway, a master regulator of inflammatory gene expression. In the context of renal inflammation, this anti-inflammatory action reduces the tissue damage that accompanies stone formation and urinary tract infections. The anti-inflammatory effects of rosmarinic acid extend to chronic liver injury, arthritis, cardiovascular diseases, and neurodegenerative disorders.

5. Antidiabetic Action: PTP1B Inhibition and Insulin Sensitization

The antidiabetic mechanism involves inhibition of protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of insulin signaling. PTP1B dephosphorylates the insulin receptor and its downstream substrates, terminating the insulin signal. By inhibiting PTP1B, the plant extract prolongs and enhances insulin signaling, improving glucose uptake in peripheral tissues. Methyl rosmarinate was identified as a PTP1B inhibitor that improves insulin sensitivity in diabetic mice. Seven pimarane diterpenoids from Orthosiphon aristatus also exhibited PTP1B inhibitory activity. This mechanism addresses the core pathology of insulin resistance in type 2 diabetes.

Traditional and Ethnobotanical Uses

1. Urinary Tract Infections and Kidney Stones

Formulation: Leaf tea, standardized extract.

Preparation and Use: The traditional preparation is a tea made by steeping two grams of dried Orthosiphon leaves in 150 milliliters of boiling water for 15 minutes. Up to six cups may be consumed throughout the day, with additional fluid intake of at least two liters daily to support the flushing action. In traditional Javanese medicine, the leaves are prescribed for kidney stones and dysuria. For urinary tract infections, the tea is consumed regularly to mechanically flush bacteria from the urinary tract while the antimicrobial compounds address the infection.

Scientific Validation: The clinical study demonstrating non-inferiority to alpha-blockers for stone expulsion provides strong validation for this traditional use. The ESCOP endorsement for flushing the urinary tract in inflammatory conditions and renal gravel confirms the traditional indication. The mechanism involves increased urine flow, alkalinization of urine, and inhibition of crystal adhesion to renal tubular cells.

2. Hypertension

Formulation: Leaf decoction, jamu preparation.

Preparation and Use: In Javanese traditional medicine, the water decoction of Orthosiphon leaves is prescribed for hypertension. The decoction is prepared by boiling the dried leaves in water and consuming the resulting liquid. The plant is a component of jamu, the traditional Indonesian herbal medicine system, for cardiovascular conditions.

Scientific Validation: The identification of Orthosiphon aristatus as the species with the highest use value for cardiovascular diseases among rural Thai people provides ethnopharmacological validation. The isolation of methylripariochromene A, which produces continuous blood pressure reduction in hypertensive rats, provides a mechanistic basis for the antihypertensive effect. The vasorelaxant activity on aortic smooth muscle and inhibition of Na+,K+-ATPase further support the traditional use.

3. Diabetes and Kidney Diseases

Formulation: Leaf tea, aqueous extract.

Preparation and Use: In southern China, Orthosiphon aristatus is a well-known traditional Chinese medicine used for treating diabetes and kidney diseases. The leaves are prepared as a tea or decoction and consumed regularly. The plant is also used in traditional medicine for rheumatism, tonsillitis, and menstrual disorders.

Scientific Validation: The identification of methyl rosmarinate as a PTP1B inhibitor that improves insulin sensitivity in diabetic mice provides a molecular mechanism for the antidiabetic effect. The traditional use of the plant for diabetes and kidney diseases is thus supported by modern pharmacological investigation into its bioactive constituents.

4. Cuts and Wounds

Formulation: Crushed leaf poultice.

Preparation and Use: The Manobo tribe of Agusan del Sur in the Philippines uses Orthosiphon aristatus for cuts and wounds. One to three crushed leaves are applied as a poultice to the affected area once or twice daily or as needed. The antimicrobial and anti-inflammatory properties of the leaves support this traditional topical application.

Scientific Validation: The antimicrobial activity of phenolic metabolites from Orthosiphon aristatus, including inhibition of Gram-positive bacteria, provides a rational basis for the use of the plant on wounds. The anti-inflammatory action reduces swelling and pain, while the antimicrobial compounds prevent infection.

5. Regional Ethnomedicinal Applications Summary

Malaysia and Indonesia: Known as Misai Kucing in Malaysia and Kumis Kucing in Java, the plant is the most widely used traditional medicine for urinary tract infections, kidney stones, and hypertension. It is a component of jamu preparations for promoting urination and cleansing the kidneys.

Thailand: Known as Yaa-nuad-maew, the plant is used by rural Thai people for cardiovascular diseases and dysuria, with the highest use value among medicinal plants for cardiovascular conditions.

China: Known as Mao xu cao, it is a traditional Chinese medicine in southern China for treating diabetes and kidney diseases.

Philippines: Known as Kabling parang, the Manobo tribe uses crushed leaves as a poultice for cuts and wounds, and the plant is also used for hypertension.

Vietnam: Known as Rau-meo, the plant is used in traditional medicine, and the aerial parts have been the subject of phytochemical investigation for antimicrobial compounds.

Healing Recipes, Teas, Decoctions, and External Applications

1. Java Tea Urinary Flush for Kidney Stones and UTIs

Purpose: A traditional tea to increase urine volume, flush the urinary tract, and support the management of kidney stones and urinary tract infections.

Preparation and Use: Place two grams (approximately one teaspoon) of dried Orthosiphon aristatus leaves in a cup. Pour 150 milliliters of boiling water over the leaves. Cover and steep for 15 minutes. Strain and drink warm. Up to six cups may be consumed throughout the day, spread evenly between meals. Crucially, additional fluid intake of at least two liters of water per day must be maintained during treatment to support the flushing action and prevent dehydration. This tea is suitable for daily use during acute episodes and for prevention in individuals with a history of urinary calculi.

Scientific Validation: The ESCOP recommends Orthosiphon leaf preparations for flushing the urinary tract in inflammatory conditions and renal gravel, and for supporting the treatment of bacterial urinary tract infections. The clinical study demonstrating comparable stone expulsion rates to alpha-blockers provides strong evidence for this indication. The hot water extract is particularly rich in rosmarinic acid and caffeic acid derivatives, which constitute over 94 percent of the identified phenolics, ensuring optimal extraction of the active diuretic and anti-inflammatory compounds.

2. Orthosiphon and Corn Silk Decoction for Enhanced Diuresis

Purpose: A synergistic decoction combining Orthosiphon with corn silk to enhance urine production and soothe the urinary tract.

Preparation and Use: Combine 10 grams of dried Orthosiphon aristatus leaves with 10 grams of dried corn silk (Zea mays stigma). Add to 500 milliliters of water in a stainless steel pot. Bring to a boil, then reduce heat and simmer for 15 minutes. Remove from heat and strain. Drink 100 milliliters of the warm decoction three times daily. Maintain increased water intake throughout the day. Corn silk is traditionally used as a gentle diuretic and demulcent, complementing the flushing action of Orthosiphon while soothing irritated urinary mucosa.

Scientific Validation: Both Orthosiphon and corn silk are recognized diuretic agents in traditional medicine. The combination enhances urine volume through complementary mechanisms while the demulcent properties of corn silk soothe the urinary tract during the flushing process. The anti-inflammatory compounds from Orthosiphon reduce the tissue inflammation that accompanies stone passage and infection.

3. Orthosiphon Leaf Poultice for Wounds and Skin Infections

Purpose: A topical application to support wound healing and prevent infection.

Preparation and Use: Harvest fresh Orthosiphon aristatus leaves. Wash thoroughly and crush them into a coarse paste using a mortar and pestle. Apply one to three crushed leaves directly to the affected area as a poultice. Cover with a clean cloth if needed. Apply once or twice daily or as needed. For larger areas, a larger quantity of crushed leaves can be used. The poultice should be replaced with fresh material at each application.

Scientific Validation: The Manobo tribe of the Philippines traditionally uses crushed leaves as a poultice for cuts and wounds. The antimicrobial activity of phenolic metabolites from Orthosiphon aristatus, including inhibition of Gram-positive bacteria such as Staphylococcus aureus and Bacillus cereus, provides a rational basis for this use. The anti-inflammatory compounds reduce local swelling and pain, while the antimicrobial constituents prevent infection.

4. Orthosiphon and Ginger Tea for Metabolic Support

Purpose: A warming tea combining Orthosiphon with ginger to support metabolic health, particularly in individuals with insulin resistance or metabolic syndrome.

Preparation and Use: Combine one teaspoon of dried Orthosiphon aristatus leaves with a half-teaspoon of freshly grated ginger and a pinch of cinnamon powder. Place in a cup and pour 200 milliliters of boiling water over the mixture. Cover and steep for 10 minutes. Strain and drink warm. Consume once or twice daily, preferably before meals. Ginger provides a warming, digestive-stimulating effect that complements the cooling, diuretic action of Orthosiphon, making the tea suitable for individuals with a tendency toward cold or sluggish digestion.

Scientific Validation: The identification of methyl rosmarinate from Orthosiphon aristatus as a PTP1B inhibitor that improves insulin sensitivity in diabetic mice provides a molecular basis for the metabolic benefits. The traditional use of the plant in southern China for treating diabetes supports this application. Ginger and cinnamon are traditional warming carminatives that enhance digestion and circulation, complementing the metabolic effects of Orthosiphon while improving palatability and tolerance.

5. Orthosiphon Foot Soak for Swollen Feet and Ankles

Purpose: An external application to reduce mild fluid retention and swelling in the lower extremities.

Preparation and Use: Prepare a strong decoction by boiling 30 grams of dried Orthosiphon aristatus leaves in two liters of water for 20 minutes. Strain and allow the decoction to cool to a comfortably warm temperature. Pour into a foot basin and soak the feet and ankles for 15 to 20 minutes. This can be done once or twice daily. The warm soak promotes local circulation while the plant's diuretic and anti-inflammatory compounds are absorbed through the skin.

Scientific Validation: While the primary diuretic action of Orthosiphon is systemic, the warm foot soak provides local vasodilation and the plant's anti-inflammatory compounds may reduce local swelling. This application is supportive rather than a replacement for internal treatment of significant fluid retention. The traditional use of the plant for edema and fluid retention provides ethnomedicinal context, though the EMA assessment notes that edema due to cardiac or renal insufficiency is a contraindication for internal use.

Clinical Significance and Evidence Summary

1. Evidence Hierarchy by Activity

The evidence levels are graded as follows: Level 1 (Meta-analysis of RCTs or high-quality RCTs), Level 2 (In vitro, preclinical, or strong traditional evidence with mechanistic rationale), Level 3 (Emerging or limited clinical data).

Diuretic and Anti-urolithic: Level 1. A randomized clinical trial comparing Orthosiphon aristatus to alpha-blockers for stone expulsion following extracorporeal shockwave lithotripsy demonstrated non-inferiority, with treatment success rates of 69.0 percent versus 54.8 percent respectively. The ESCOP endorsement for flushing the urinary tract provides additional authoritative validation. The EMA assessment report confirms the traditional use for increasing urine to achieve flushing of the urinary tract.

Antihypertensive: Level 2. Strong preclinical evidence from multiple models, including stroke-prone spontaneously hypertensive rats, with identification of the active constituent methylripariochromene A. The ethnopharmacological use value for cardiovascular diseases is the highest among medicinal plants in a rural Thai study. Clinical trials specifically on blood pressure endpoints are needed to advance to Level 1.

Antidiabetic: Level 2. Preclinical evidence demonstrating PTP1B inhibition and improved insulin sensitivity in diabetic mice, with identification of methyl rosmarinate as the active compound. Traditional use in China for diabetes provides ethnomedicinal support. Clinical trials are needed.

Anti-inflammatory: Level 2. Strong mechanistic evidence for rosmarinic acid inhibiting TNF-alpha, IL-6, IL-1beta, COX-2, and iNOS. Preclinical evidence in models of Alzheimer-like pathology and chronic inflammatory conditions. Clinical trials in specific inflammatory conditions are needed.

Antimicrobial: Level 2. In vitro evidence of antimicrobial activity against Gram-positive and Gram-negative bacteria and Candida albicans, with MIC values of 75 to 300 micromolar for isolated compounds. Clinical trials on urinary tract infections are needed to confirm clinical relevance.

2. Clinical Data on Stone Expulsion

The clinical study conducted at Uttaradit Hospital in Thailand represents the most rigorous clinical investigation of Orthosiphon aristatus to date. A total of 84 patients with urinary tract calculi undergoing extracorporeal shockwave lithotripsy were randomized to receive either Orthosiphon aristatus or the alpha-blocker doxazosin (2 milligrams) for three months. Patients were followed every two weeks with imaging and laboratory tests. The stone-free rate was 47.6 percent in the Orthosiphon group and 45.2 percent in the alpha-blocker group. The treatment success rate, a broader endpoint including clinically insignificant residual fragments, was 69.0 percent in the Orthosiphon group and 54.8 percent in the alpha-blocker group. Neither difference was statistically significant, indicating that the herbal preparation is as effective as the standard pharmaceutical for medical expulsive therapy. The complication rates were also statistically indistinguishable. This study provides robust clinical evidence for the traditional use of Orthosiphon for kidney stones and establishes it as a viable alternative to alpha-blockers for facilitating stone passage after lithotripsy.

3. Study Limitations and Research Needs

While the clinical evidence for stone expulsion is strong, several limitations must be acknowledged. The anti-urolithic clinical trial was conducted at a single center with a relatively small sample size of 84 patients. Larger, multi-center trials are needed to confirm the findings and establish generalizability. The antihypertensive and antidiabetic activities are primarily supported by preclinical evidence; clinical trials with blood pressure and glycemic endpoints are urgently needed. The plant's efficacy in urinary tract infections has not been evaluated in randomized controlled trials, though traditional use and in vitro antimicrobial evidence are supportive. The case report of hepatitis associated with a combination product containing Orthosiphon and green tea warrants further investigation to determine whether Orthosiphon contributed to the adverse event or whether green tea was the causative agent. Priority research needs include: a multi-center randomized controlled trial on Orthosiphon for ureteral stone expulsion as monotherapy; clinical trials on blood pressure reduction with standardized extracts; and controlled studies on glycemic control in prediabetic and diabetic populations. The long-term safety of standardized extracts beyond three months has not been established.

Drug Interactions

The clinical significance of interactions is considered moderate for lithium, and low for other medications based on available data.

Lithium Interaction: Orthosiphon aristatus interacts with lithium. The diuretic effect of the plant may reduce lithium clearance, leading to increased serum lithium levels and potential toxicity. Concomitant use should be avoided, or lithium levels should be monitored closely if co-administration is necessary.

Additive Diuretic Effect: When combined with pharmaceutical diuretics such as furosemide or hydrochlorothiazide, Orthosiphon may produce an additive diuretic effect, potentially leading to excessive fluid and electrolyte loss. Monitoring of hydration status and electrolytes is advised.

Additive Antihypertensive Effect: The vasorelaxant and Na+,K+-ATPase inhibitory activities of Orthosiphon may produce an additive hypotensive effect with antihypertensive medications. Blood pressure should be monitored when initiating the herb, particularly in individuals on multiple antihypertensive agents.

Potential Hypoglycemic Interaction: The PTP1B inhibitory activity suggests a potential additive effect with antidiabetic medications, including insulin, sulfonylureas, and metformin. Blood glucose monitoring is advised when combining the herb with pharmaceutical antidiabetic agents.

Final Summary of Contraindications and Precautions

Absolute Contraindications:

· Known hypersensitivity to Orthosiphon aristatus or other plants in the Lamiaceae family.

· Edema due to cardiac or renal insufficiency. The increased fluid load from the diuretic effect may exacerbate these conditions.

· Concomitant use with lithium.

Use with Caution:

· Individuals with existing electrolyte imbalances or dehydration (the diuretic effect may worsen these conditions; adequate fluid intake is essential).

· Individuals on pharmaceutical diuretics (monitor for additive effects and electrolyte depletion).

· Individuals on antihypertensive medication (monitor blood pressure for additive effects).

· Individuals on antidiabetic medication (monitor blood glucose for potential additive hypoglycemic effects).

· Children and adolescents under 18 years of age (use not recommended due to insufficient data).

· Pregnancy and breastfeeding (use not recommended due to insufficient safety data).

· Individuals with symptoms of fever, dysuria, spasms, or blood in the urine (seek medical advice before use).

· Scheduled for elective surgery (discontinue at least 2 weeks prior due to potential diuretic and hypotensive effects).

Disclaimer: This monograph is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare practitioner before using herbal medicines, especially in the context of existing medical conditions or concurrent pharmaceutical treatments. Adequate fluid intake must be maintained during treatment with Orthosiphon aristatus to support the flushing action and prevent dehydration.